Multicenter Investigation of the Opioid Antagonist Nalmefene in the Treatment of Pathological Gambling

Naltrexone in the Treatment of Alcohol Dependence

1992 • 1,875 citations

Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.

1999 • 1,242 citations

Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling

2001 • 476 citations

Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial

1999 • 432 citations

Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine

1984 • 424 citations

Naltrexone, an Antagonist for the Treatment of Heroin Dependence

1973 • 395 citations

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling

2000 • 290 citations

A Double-blind, Placebo-Controlled Study of Oral Nalmefene for Alcohol Dependence

1999 • 276 citations

Role of Dopamine D₁and D₂Receptors in the Nucleus Accumbens in Mediating Reward

1997 • 248 citations

Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area

1984 • 219 citations

Does Sustained-Release Lithium Reduce Impulsive Gambling and Affective Instability Versus Placebo in Pathological Gamblers With Bipolar Spectrum Disorders?

2004 • 216 citations

Role of opioid antagonists in treating intravenous cocaine abuse

1989 • 126 citations

Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area

1979 • 120 citations

Naltrexone-induced dysphoria in former opioid addicts

1985 • 91 citations

Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist

1987 • 73 citations

Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial

2003 • 42 citations

Changes in Transaminases Over the Course of a 12‐Week, Double‐Blind Nalmefene Trial in a 38‐Year‐Old Female Subject

1994 • 11 citations